Selected Publications
Pan HM, McClelland RL, Moutchia J, Appleby DH, Fritz JS, Holmes JH, Minhas J, Palevsky HI, Urbanowicz RJ, Kawut SM, Al-Naamani N: Heterogeneity of treatment effects by risk in pulmonary arterial hypertension Eur Respir J 62 (1): 2300190,2023.
McCarthy BE, McClelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, Urbanowicz RJ, Holmes JH, Palevsky HI, Kawut SM, Al-Naamani N: BMI and treatment response in patients with pulmonary arterial hypertension: a meta-analysis Chest 162 (2): 436-447,2022.
Matura LA, Fargo JD, Boyle K, Fritz JS, Smith KA, Mazurek JA, Pinder D, Archer-Chicko CL, Palevsky HI, Pack AI, Sommers MS, Kawut SM: Symptom phenotypes in pulmonary arterial hypertension: the PAH "symptome" Pulm Circ 12 : e12135,2022.
Min J, Appleby DH, McClelland RL, Minhas J, Holmes JH, Urbanowicz RJ, Pugliese SC, Mazurek JA, Smith KA, Fritz JS, Palevsky HI, Suh JM, Al-Naamani N, Kawut SM: Secular and regional trends among pulmonary arterial hypertension clinical trial participants Ann Am Thorac Soc 19 (6): 952-961,2022.
Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N: Systemic arterial properties in pulmonary hypertension Pulm Circ 11 (4): 1-3,2021.
Herzig M, Khandhar S, Palevsky H, Fritz J, Mehta M, Matthai W: Intermediate-term outcomes for patients with submassive pulmonary embolism treated with catheter-directed thrombolysis J Invasive Cardiol 33 (12): E949-E953,2021.
Frost A, Janmohamed M, Fritz JS, McConnell JW, Poch D, Fortin TA, Miller CE, Chin KM, Fisher M, Eggert M, McEvoy C, Benza RL, Farber HW, Kim NH, Pfister T, Shiraga Y, McLaughlin V: Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: results from the TRANSIT-1 study J Heart Lung Transplant 38 (1): 43-50,2019.
Boyle K, Fargo JD, Fritz JS, Smith KA, Mazurek JA, Pinder D, Archer-Chicko CL, Palevsky HI, Pack AI, Sommers MS, Kawut SM, Matura LA: Reliability and construct validity of the patient-reported outcomes measurement information system (PROMIS) instruments in women with pulmonary arterial hypertension Am J Respir Crit Care Med 197 : A2640,2018.
Narasimhan V, Palevsky HI, Smith KA, Fritz JS, Mazurek JA, Archer-Chicko CL, Burwell C, Pugliese S, Kawut SM, Al-Naamani N: Obesity in pulmonary arterial hypertension Am J Respir Crit Care Med 197 : A5709,2018.
Baird GL, Archer-Chicko C, Barr RG, Bluemke DA, Foderaro AE, Fritz JS, Hill NS, Kawut SM, Klinger JR, Lima JAC, Mullin CJ, Ouyang P, Palevsky HI, Palmisicano AJ, Pinder D, Preston IR, Roberts KE, Smith KA, Walsh T, Whittenhall M, Ventetuolo CE: Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Eur Respir J 51 (6): 1800467,2018.
Academic Contact Information
Harron Lung Center
Pulmonary Vascular Disease Program
Penn Medicine University City
3737 Market St., 10th Floor
Philadelphia,
PA
19104
Phone: 215-662-8766
Patient appointments: 800-789-7366